Narrow down your results by adding or subtracting another category. Numbers in the columns below indicate how many stories will be shown as a result of adding / removing each category. [ Help ]
Help
To narrow down your selection of articles, click on the "AND" or "NOT" next to any of the categories below. Say you’re currently browsing entries in category "A", you can then drill down into entries that belong both to category A and another category, or belong to category A but not another category. For instance, you could list entries about demographics in the automotive sector, or entries about email marketing that are not about spam. Numbers in the columns below indicate how many entries the selected operation will narrow your query to. You can combine multiple intersection and exclusion criteria to further limit the number of entries.
| Your current selection | AND | NOT |
|---|---|---|
| » ad buying & planning | 2 | |
| » ad selling | 2 | |
| » ad targeting | 1 | 1 |
| » ad technologies & vendors | 1 | 1 |
| » healthcare | 1 | 1 |
| » legal, government & regulation | 1 | 1 |
| » major brands | 1 | 1 |
| » major players news | 1 | 1 |
| » measurement & analytics | 1 | 1 |
| » media convergence | 1 | 1 |
| » online ad market | 1 | 1 |
| » signs of doom | 1 | 1 |
| » signs of recovery | 1 | 1 |
| » signs of what's to come | 1 | 1 |
| » text ads | 1 | 1 |
- Showing 1 - 2 of 2
Higher Google Earnings Point to Online Ad Recovery
Google's recent earnings increase is a positive sign for the search-engine giant, whose growth is being led by recovering online search ad activity, and could mean at least some future recovery for a larger chunk of the online ad market in the coming months.Â
Google reported revenues of $5.94 billion for Q3 2009, an increase of 7% compared with Q3 2008. GAAP net income in the third quarter of 2009 was $1 [...]
Posted: Monday, October 19th 2009
Pharma Steps Back from Sponsored Ads
Pharmaceutical companies are struggling to reconcile online marketing techniques with a stepped-up oversight campaign by the Food and Drug Administration's Division of Drug Marketing, Advertising and Communications (DDMAC), which is specifically targeting such activities.
While industry-regulatory give and take on marketing is a long-standing and complicated dance, recent events appear to have caused pharma companies to take a step back from several strategies – at least until they can be s [...]
Posted: Friday, October 16th 2009
- Showing 1 - 2 of 2